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I. INTRODUCTION 
A. OBJECTIVE 
The overall objective of this research is to attempt to 
modify factors which promote disuse osteoporosis and thereby 
prevent it from occurring. 
B. BACKGROUND 
Disuse Osteoporosis: Bone mineral is lost when the 
mechanical factors present during normal ambulation are removed. 
Negative calcium balance and/or osteopenia have been observed 
during several clinical and experimental conditions in people 
including acute and convalescent phases of paralytic anterior 
poliomyelitis (2), immobilization due to casting in both fracture 
patients ( 3 )  and normal young men (4) and in space travel (5). 
The mechanism of bone loss is thought to be a normal adaptive 
function upon exposure to hypogravic states (7). A reproducible 
model of disuse osteopenia in studies of healthy young males 
during prolonged bed rest without immobilization has been 
developed (4,6,8). Using bed rest as a model to produce disuse 
osteoporosis, calcium loss from the whole skeleton has been 
measured by balance techniques and averages 0.5% of total body 
calcium per month (6,8). Ten fold greater rates of loss from the 
central portion of the calcaneus have been observed by gamma ray 
transmission scanning (6,8). 
Mineral loss during bed rest is probably due to a 
reduction in the forces which are applied to the skeleton during 
normal activity (4,6,8). These one llG1l homeostatic forces are 
absent also in the hypogravic environment of space flight. Loss 
of bone mineral during space flight is expected on theoretical 
grounds and has been confirmed in the Skylab experiments (5,9). 
This factor might prove hazardous to astronauts on flights of 
long duration, not only because hypercalciuria might lead to the 
formation of renal calculi during flight, but axial skeletal 
fractures may occur upon re-entry to earth's gravity. 
The need to reduce these hazards has led to a series of 
experiments. Various therapeutic attempts to prevent the negative 
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calcium balance and loss of calcaneal density during prolonged 
bed rest have met with only limited success. Other studies 
designed to apply either compressive and/or tensile forces to the 
skeleton during bed rest have been performed. Unfortunately these 
studies were not able to demonstrate a direct effect of either in 
preventing disuse osteoporosis. Mechanical methods tried were: 1) 
Use of the Exergenie apparatus (6) which consisted of a rope 
which was pulled back and forth through a pulley, the friction of 
which was preset to provide 8 lbs of resistance. An exercise 
program was performed in the supine position f o r  80 minutes per 
day. This program failed to diminish any of the metabolic changes 
of bed rest and did not prevent mineral loss from the calcaneus. 
2) Longitudinal compression was attempted using the gravitational 
acceleration simulating suit (@GASS) . This was tested in two 
ways: (@a) static compression applying 80% of the body weight 
from the shoulders to the soles of the feet for 3 hours daily 
(6,lO) ; and (@b.) intermittent longitudinal compression at a rate 
of 4 5  compressions/min for 200 min/day (6). This treatment did 
not prevent the negative calcium balance nor the usual loss of 
calcaneal mineral. 3 )  Impact loading of the axial skeleton to 
create piezoelectrical forces was tested (6). Thirty-five l b s  of 
impact load to each heel and compression of 80% of body weight to 
the axial skeleton was performed 6 hours daily. Although 
calcaneal mineral density remained the same or increased during 
this therapy, overall calcium loss was equal to that in untreated 
bed rest. 4 )  Quiet standing was studied; i.e., the subject stood 
without lifting either foot for 3 hours each day (11). Neither 
calcaneal mineral density nor calcium balance was protected. 5)  
Three hours of quiet standing plus 20 min. of bicycle ergometry 
exercise daily did not provide any protection (11). 6) Three 
hours of normal ambulation plus 21 hours of bed rest started 
after 6 weeks of total demonstrated some protection from the 
usual negative calcium balance (11). 
Five biochemical regimens have been studied: 1) 
synthetic salmon calcitonin (10) , a hormone which inhibits bone 
resorption (@lo0 MRC U), was given daily by injection during 8 
weeks of bed rest; 2) phosphate supplements in order to reduce 
urinary calcium excretion was given in divided doses as a neutral 
potassium salt (12) ; 3 )  oral calcium and phosphate with the hope 
that the former would increase calcium absorption from the 
intestine while the latter would decrease calcium excretion in 
the urine was given in divided doses (6,12); and 4) the 
diphosphonate EHDP either as a 5 mg/kg/day dose or as a 20 
mg/kg/day dose (13). Little or no protection was afforded by the 
first three methods during long-term bed rest. Low dose 
diphosphonate showed no beneficial effect. 
The high dose EHDP appeared to have a protective effect 
starting in the 16th of 20 weeks of bed rest. The effects of the 
20 mg/kg/day dose was assessed by three largely independent 
techniques: 1) metabolic balance; 2) 1251 gamma ray transmission 
scanning of the calcaneus; and 3 )  47Ca kinetic studies. In weeks 
2-12, the usual patterns of hypercalciuria, hyperphosphaturia and 
negative calcium and phosphorus balances were seen. During the 
last 8 weeks of bed rest, a shift towards positive calcium and 
phosphorus balance occurred. Urinary hydroxyproline excretion 
decreased in distinct contrast to the rise which is usually seen. 
The serum phosphorus level rose promptly, persisted at levels 
about 3 mg/dl above baseline during EHDP therapy and fell to 
normal levels promptly upon discontinuation of the drug. Serum 
alkaline phosphatase values tended to decline throughout the 
treatment period. Serum total and ionized calcium concentrations 
remained unchanged during the 20 weeks of bed rest. The subjects 
lost significant amounts of mineral from the calcaneus during the 
first 17 weeks of bed rest. During the last 3 weeks of bed rest, 
the usual progression of calcaneal mineral loss was no longer 
observed. Calcium kinetic studies during therapy revealed that 
bone accretion and resorption rates fell progressively and in 
parallel fashion to levels 50% below baseline by the end of bed 
rest. 
Clodronate, another diphosphonate, prevented disuse 
osteoporosis during 17 weeks of bed rest (6): however, this drug 
has been withdrawn from clinical investigation. 
Fluoride is currently used to enhance bone formation in 
the treatment of low turnover osteoporosis. In previous short 
term bed rest ( @ 5  weeks), 20 mg F given as a sodium fluoride 
divided into three doses was not effective in reducing calcium 
balance loss. Fluoride balance was found to be positive 
suggesting that fluoride in small doses and given for a short 
period of time could not change the usual disuse osteoporosis of 
bed rest. Concern was voice that high levels of fluoride ion may 
have been available for only short periods of time and therefore 
was not able to change bed rest induced calcium changes. We 
hypothesized that if the fluoride ion was available over a much 
longer period of time, e.g. as could now be accomplished by a 
slow release wax matrix preparation, fluoride would slow the loss 
of calcium by 1) inhibiting bone resorption and 2) enhancing bone 
formation. 
EFFECT OF SODIUM FLUORIDE ON BONE MINERAL LOSS DURING BED REST 
A .  HYPOTHESIS 
To determine whether low levels of sodium fluoride can 
prevent bone mineral l o s s  during five weeks of bed rest. 
B. INTRODUCTION 
Industrial workers exposed to moderate doses of 
compounds containing fluoride and people who ingest higher than 
usual F in their daily water may develop asymptomatic increased 
skeletal radiodensity (14,20). In 1961, F treatment f o r  
osteoporosis was tried by Rich and Ensinck (15) in hopes that the 
induction of sub-clinical fluorosis might strengthen an 
osteopenic skeleton. They reported that calcium retention ensued. 
F substitutes for the hydroxyl group in the 
hydroxyapatite crystal which leads to a less soluble crystal 
system (36). F also stimulates osteoblastic activity (34,35), and 
therefore, with adequate calcium intake, calcium retention is 
enhanced (16) . 
High dose F has been known to cause a crippling bone 
disease characterized by dense bones, exostoses and neurological 
complications due to bony overgrowth and ligamentous 
calcification. When given in small doses (@less than 25 mg F 
ion), little or no problems have been reported in the literature 
(16). The side effects from low dose F include gastric irritation 
(@which is usually obviated when the F is given with meals, by 
enteric coated tablets or in a slow release was matrix form); 
transient arthralgia and stiffness of the joints may rarely 
occur. 
To determine whether smaller doses of F would increase 
calcium balance without causing severe side effects, we studied 
ambulatory (18) and bed rested subjects receiving 5 or 10 mg F 
daily. These low doses of F did not cause changes in calcium 
balances in the ambulatory subjects and did not protect against 
bed rest induced calcium loss. Therefore the effects of 20 mg F 
daily were studied (xx). This is the minimal dose usually used 
therapeutically. We were not able to show any decrease in calcium 
loss by balance technique. However, since fluoride has been shown 
in other studies to increase bone mass, we felt that there must 
be an incremental fluoride effect in both its bone resorption 
protection and bone formation stimulation. The fluoride in the 
previously reported study was given to the research subjects as 
fast absorbing sodium fluoride in divided doses an hour before 
each meal. This would have caused extremely high blood levels of 
flouride for short periods followed by long periods of time 
without additional fluoride. Therefore slow release wax matrix 
embedded sodium fluoride was given so a constant increase of 
fluoride ion would be absorbed. 
C. SPECIFIC AIMS 
1. To determine whether oral medication with sodium F 
will modify or prevent 5 weeks of bed rest induced disuse 
osteoporosis as assessed by standard metabolic balance, lumbar 
vertebrae and calcaneus, and Tc99m MDP kinetic techniques. 
2. To determine the longitudinal effects of 5 weeks of 
bed rest on PTH, CT and calcitriol on controls and treated 
subjects. 
3. To measure muscle volume changes and metabolic 
activity by magnetic resonance imaging and magnetic resonance 
spectroscopy techniques during prolonged bed rest. 
4 .  To measure changes in peak muscle strength and 
muscle fatigability during prolonged bed rest. 
5. To measure bone turnover in bone biopsies during 
prolonged bed rest. 
D. METHODS OF PROCEDURE 
Subjects were studied during 1 week of equilibration, 4 
weeks of control ambulation, 5 weeks of bed rest, and 1 week of 
reambulation. Progress was monitored by: (@a) calcium, 
phosphorus, and nitrogen balance studies and urinary 
hydroxyproline and creatinine: (@b) gamma ray transmission 
scanning of the calcaneus, and lumbar vertebrae: (@c) Tc99m MDP 
kinetic studies; (@d) fasting hormonal responses during 
ambulation and bed rest: (@e) magnetic resonance imaging of the 
leg (@f) Cybex muscle strength testing; and (@f) bone biopsy. 
A. RESEARCH SUBJECTS 
Eighteen subjects were studied during 11 weeks of 
continuous metabolic ward living: 12 received F and 6 served as 
untreated controls. Random assignment of therapeutic choices 
occurred. 
The subjects were males between the ages of 22-61, who 
respond to a request for research subjects from the general 
population. The volunteers were screened by the PI and members of 
the Clinical Research Center staff. Routine laboratory screening 
was done prior to acceptance to rule out any ongoing health 
problems which would be cause for subject exclusion. The research 
subjects were made employees of Krug International, Houston, Tx 
77058 and were entitled to worker's compensation for any untoward 
effects during the study. No ill effects were reported nor could 
we determine that any had occurred from this study. 
Each subject participating in the study provided the 
investigator with signed consent, which gave the investigator 
permission to study the volunteer. The consent form indicated 
that the volunteer had been informed about the objectives of the 
study, procedures to be used, and of all known possible problems 
the volunteer may experience as a study participant. 
Subjects were housed on the Metabolic Wards of the 
Clinical Research Centers at Methodist or Hermann Hospital in 
Houston, in private or semi-private rooms. During the 
equilibration week, all respective research subjects underwent a 
prestudy examination as outlined below. All tests were carried 
out according to standard techniques in the clinical laboratories 
of NASA-Johnson Space Center, Houston. These examinations 
provided baseline observations and, in addition, served to detect 
. 
and eliminate 
criteria. 
volunteers who did not fulfill subject selection 
1. Characteristics Which Excluded a Volunteer from the 
Study Include 
a. Acute disease other than acute upper 
respiratory infections and minor skin diseases, e.g., 
dermatophytosis 
Chronic diseases other than minor skin b. 
diseases, e.g., acne 
c. Medications which by their action interfere 
d. Recent sub-standard nutritional status which 
with the interpretation of results, e.g., fluoride, estrogen 
may have altered the metabolic milieu 
2. Medical History and Physical Examination 
A. 'medical history was taken and physical 
examination performed and recorded. In addition to the routine 
examination, additional tests included: 
a. Neurologic evaluation 
b. Dental, ear, nose and throat examination 
c. Eye examination 
d. Standard 12 lead electrocardiogram 
e. Urinalysis 
f. Stool for occult blood 
g. Complete blood count 
h. Fasting blood glucose 
i. Serologic test for syphilis 
j. Serum 
k. Serum 
1. Serum 
m. Serum 
n. Serum 
0. Serum 
p. Serum 
q. Serum 
r. Serum 
s .  Serum 
t. Serum 
u. Serum 
v. Serum 
w. Serum 
total protein/albumin and globulin 
uric acid 
total bilirubin 
SGOT 
creatinine 
blood urea nitrogen 
alkaline phosphatase 
sodium 
potassium 
chloride 
carbon dioxide 
calcium 
phosphorus 
I hepatitis antigen, and as soon as it was 
available, HIV antigen 
x. 
y. Serum cholesterol and triglyceride 
A screen for addicting drugs 
3 .  Study Desisn 
The 11-week study was divided into three parts and 
Each part of the involved a total of 18 normal test subjects. 
study was divided into five phases: 
a. Phase I (@week 1) consisted of orientation. The 
subjects started the metabolic diet. The subjects also received 
polyethylene glycol 4000, underwent metabolic equilibration, and 
received a complete physical examination. 
b. Phase I1 (@week 2) was the ambulatory control period 
during which the subjects continued on the metabolic diet. 
Baseline measurements of calcium, phosphorus and nitrogen 
balance, blood PTH, CT, calcitriol, urine hydroxyproline and 
densitometric scans of the calcaneus, and lumbar spine were 
obtained. 
c. Phase I11 (@weeks 3-5) was the ambulatory load 
period during which the subjects received F, or no therapy. 
Baseline metabolic balance and hormonal and densitometric 
measurements continued during this period. Tc99m MDP kinetics 
were done in some subjects. Magnetic resonance imaging and 
spectroscopy were done in some subjects. Cybex muscle testing was 
performed. 
d. Phase IV (@weeks 6-10) was the bed rest period, 
during which the subjects were at strict bed rest and received F 
or no therapy. Metabolic balance continued and hormonal and 
densitometric measurements obtained. Tc99m MDP kinetics were done 
in some subjects. Bone biopsies were taken at week 5 of bed 
rest in six subjects (three controls and three treated) who had 
been labeled with tetracyline and doxicyline once during the 
ambulatory phase and once toward the end of bed rest. 
e. Phase V (@week 11) was the reambulation period. The 
F and balance studies were discontinued at the end of bed rest. 
Densitometry, magnetic resonance imaging and spectroscopy and 
Cybex testing were performed as soon as feasible after the end of 
bed rest. 
Ambulatory Bed Rest 
No. of Subjects (@weeks 3-5) (@weeks 6-10) 
12 25 m g / d  F 25 m g / d  F 
6 no therapy no therapy 
The studies were done on an ongoing basis over the 
course of several years. Two or more subjects were allowed to 
begin a study as soon as they were identified and additional 
subjects were added as they were identified. 
4. Medications Studied: 
Study Drug: Sodium Fluoride U.S.P. (@Package 
Insert) Sodium fluoride occurs as an odorless, 
white, crystalline powder prepared from a naturally occurring 
fluoride such as fluorospar (@CaF2) or cryolite (@Na3AlF6). It 
contains approximately 45% fluoride ion and is soluble in water 
and insoluble in alcohol. Solutions of sodium fluoride have a pH 
c 
of 7 and are stable but should be stored and dispensed in 
plastic, or in paraffin-lined glass, or U.S.P. type I 
borosilicate glass containers. 
The mechanism of action of sodium fluoride in 
reducing tooth decay is not fully understood, but it appears that 
the most important effect is upon the formation of tooth 
structure before the teeth erupt. Fluorides are known to be 
incorporated into the teeth by occupying sites otherwise occupied 
by hydroxyl, and perhaps carbonate, groups in the apatite 
structure of the tooth enamel. The reaction, resulting in the 
formation of fluorapatite, is apparently irreversible. 
Fluorapatite is formed from ingested fluoride while the enamel is 
calcifying, during the pre-eruptive period and after the teeth 
have erupted. When concentrated fluoride solutions are applied 
topically to the teeth, calcium fluoride as well as fluorapatite 
is formed and a part of the calcium fluoride is slowly converted 
to additional .fluorapatite. Fluoride also diffuses into the 
partly demineralized enamel of initial carious lesions and reacts 
with residual apatite structures. Fluorapatite is less soluble in 
an acid medium than is hydroxyapatite, and fluoride has been 
shown to increase the resistance of enamel to acid. During the 
calcification process, fluorides may exert a catalytic action 
upon enamel crystallization which results in a more perfect 
crystalline apatite. It has been postulated also that fluoride 
catalyze remineralization. Fluorides may, in addition, inhibit 
the growth of acid-forming organisms in the mouth. 
Fluorides are readily and almost completely 
absorbed from the gastrointestinal tract following oral 
administration of soluble fluoride salts. If administered as a 
less soluble salt such as calcium fluoride or in bone meal, 
absorption is slow and variable. Absorption of high doses of 
fluorides may be decreased by simultaneous ingestion of calcium 
compounds (@such as those present in milk), but these compounds 
probably have little effect on absorption of small amounts of 
fluorides found in drinking water. A physiological, 
storage-mobilization mechanism maintains a low level of fluoride 
ion in the body and may be important in providing a constant 
supply of fluoride for developing teeth: very little fluoride 
accumulates in non-calcified tissues. Fluorides have been 
demonstrated to cross the placental barrier of animals and 
humans. They are excreted primarily in the urine; lesser amounts 
are excreted in the feces, sweat, saliva, and milk. 
Cautions (@Package Insert) 
Prolonged uses of water containing fluorides in 
concentrations of 4 to 8 parts per million may increase the 
density of bone mineral to a degree detectable by 
roentgenographic studies and apparent fluoride osteosclerosis has 
been reported. Concentrations representing over 2 parts per 
million of fluoride ion in drinking water may cause dental 
fluorosis (@mottling of tooth enamel) during the period of tooth 
development. (@Not all "white enamel opacitiesg1 are signs of 
dental fluorosis but may be the result of numerous hypoplastic 
conditions of unrelated origin). Dental fluorosis is the most 
sensitive index of chronic fluoride poisoning; the color of the 
teeth in this type of fluorosis may range from white to brown. 
Acute toxicity is not likely to result from the 
small amounts of fluorides present in drinking water, but is 
possible with concentrated solutions or tablets. It has been 
recommended that no more than 264 mg of sodium fluoride (@119 mg 
fluoride ion) be dispensed at one time, and that each container 
should be labeled IICaution: Store out of reach of chi1dren.I' 
Doses of 230 mg of sodium fluoride have caused toxic symptoms and 
lesser amounts may cause poisoning or death in children. The 
oral dose of sodium fluoride which may be fatal to an adult is 
not known with certainty, but it is estimated to be about 2 to 5 
grams. 
Symptoms of acute fluoride poisoning include 
epigastric pain, nausea, vomiting, diarrhea, and local paralysis 
in the legs and face. Epileptiform convulsions may occur. The 
respiratory center is initially stimulated and then depressed, 
and blood pressure falls. Death results from cardiac failure or 
respiratory paralysis. 
In the event of acute poisoning, dextrose and 
sodium chloride injection is given intravenously to maintain 
blood sugar levels. The stomach is washed with 1 to 5% calcium 
systemic calcium deficiency becomes apparent, calcium gluconate 
injection is administered intravenously. A high urine volume 
should be maintained by administration of intravenous fluid. 
chloride solution or with calcium hydroxide solutions. If 
Dosage (@Package Insert) 
Sodium fluoride may be administered orally or 
topically. To reduce the incidence of dental carries, 1.5 to 3 
parts per million of sodium fluoride ( e 0 . 7  to 1.3 parts per 
million of fluoride ion), or another suitable fluoride 
representing approximately 1 part per million of fluoride ion, 
may be added to municipal water supplies which contain little or 
no fluoride. In warm climates, where more water is ingested, the 
concentration of fluoride in municipal supplies should be at the 
lower end of this range. 
As an alternative to community fluoridation, 
fluoride may be added to family or individual water supplies 
under the direction of a dentist or physician. The amount of 
prescribed fluoride must be adjusted in proportion to the amount 
of fluoride provided in drinking water. Supplementary fluoride 
should be prescribed only when the concentration of fluoride ion 
in drinking water is known to be less than 0.7 parts per million 
( e 0 . 7  mg of ion per 1000 ml). When the water is devoid of 
fluoride, supplements providing approximately 0.5 mg of fluoride 
ion per day for children two to three years of age, or 1 mg per 
day for children over three years of age, may be administered. 
Tablets or concentrated solutions of sodium fluoride are suitable 
for this purpose and may be used to prepare small quantities of 
fluoridated water for administration to infants (@specific daily 
dosage for infants has not been established) or may be added to 
drinking water or other food for older children. One 2.2 mg 
tablet of sodium fluoride provides approximately 1 mg of fluoride 
ion. 
A 2% solution of sodium fluoride may be applied by 
a dentist to teeth which have been thoroughly cleaned, isolated 
with cotton rolls, and dried with jet of air. The maximal 
protective effect appears to be obtained with a treatment series 
of four applications with intervals of several days following a 
single prophylaxis. A series of treatments may be given at age 
three to provide protection to the deciduous teeth. The series 
of four applications is repeated at intervals in accordance with 
the pattern of tooth eruption of the individual patient so that 
the teeth may receive protection as soon as possible after 
eruption. It has been recommended that treatments might be given 
at three, seven, eleven, and thirteen years of age. There is 
some evidence, however, that annual treatments provide better 
protection than is obtained from less frequent applications. 
5. Other Medications: 
All subjects received a Hexavitamin tablet once 
daily which, with the diet, provided approximately 14,000 I.U. of 
vitamin A, 630 I.U. of vitamin D, 3 mg thiamin, 5 mg riboflavin, 
4 2  mg niacin, and 192 mg ascorbic acid. Dioctyl sodium sulfosuccinate (@Colace ) was given orally in a dose of 100 mg 
twice daily to prevent constipation. Polyethylene glycol 4000 
was used as a fecal marker and was given in an oral dose of 5 0 0  
mg three times daily. 
6. Test Procedures: 
a. Bone Densitometry 
Bone mineral of the calcaneus and lumbar spine 
were measured before and after bed rest. 
1. Instrumentation 
Rectilinear 1251 scanning was done by the method 
of Vogel (19) for the calcaneus; and rectilinear 153Gd scanning 
was done by the method of Mazess (22) for the lumbar spine. 
b. Calcium Kinetics 
Modified calcium kinetics were measured in some of 
the subjects by determining the urinary output of Tc99m MDP after 
the oral administration of 100 microcuries of the labeled MDP. 
c. Bone Biopsy 
week 5. 
The bone biopsies were performed 
All six subjects who had a bone 
during bed rest 
biopsy took the 
appropriate bone marking agents four times during -the 10 week 
study; twice during the ambulatory treated phase, and twice 
during the bed rest phase. The bone markers were tetracycline and 
demeclocycline which were alternated each time. Demeclocycline 
was given (orally 250 mg TID) for three days and the tetracycline 
was then given 10 days later (orally 300 mg TID) for three days. 
The labeling was done starting week 3 of ambulation and week 3 of 
bed rest. 
The iliac bone biopsy was taken through the 
lateral body wall using the appropriate bone biopsy trephine. The 
procedure was performed on the selected day. Meperidine 
hydrochloride 75 mg and diazepam 10 mg were used as premedication 
for the biopsy. The patient was placed in the supine lateral 
position, the skin was prepared with the usual aseptic 
precautions and local anesthesia, buphercaine 0.5% was used. A 2 
cm incision was made 2 cm behind the anterior superior iliac 
border and 2 cm below the iliac crest. Blunt dissection separated 
the muscle and fascia to the periosteum and the trephine was 
rotated with a power hand drill to cut evenly through the outer 
cortex, the trabecular bone and the inner cortex. One or two 7 mm 
bone cores were obtained. Normal lesion repair was made and an 
elastic pressure dressing was applied. The subject was required 
to lie on the site of the wound for one hour and then was allowed 
usual activity. 
Undecalcified bone were cut using the special bone 
microtome and standard histomorphometry was performed. 
d. Magnetic Resonance 
MRI scans were performed over the lower leg spine 
of some of the subjects. Magnetic Resonance Spectroscopy was 
performed over the muscles of the lower legs of some of the 
subjects. 
Each scan consisted of 5 slices, 2 cm apart, starting at 
the lower calf. Spectroscopy was performed for the leg. Before 
the start of the first scan, the desired start point was 
determined as the distance in centimeters from the bottom of the 
heel to a position on the calf where the gastrocnemius muscle 
mass is negligible. This is an approximate distance which, 
however, is constant for all subsequent scans. 
e. Muscle Strength Testing 
Before and a f ter  bed rest tests for muscle 
strength and muscle fatigue w e r e  performed using the Cybex. 
f .  Lean Body Mass Determination 
Lean body mass was determined using skin calipers, 
underwater weighing and 40Potassium (@40K) standard methods. The 
40K is a naturally occurring radioactive isotope found in muscle 
tissue. This low level natural marker of lean body mass will be 
measured in the NASA-Johnson Space Center whole body counter. The 
detectors are housed in a room 60 feet underground specially 
constructed for low-level counting. 
13. Safety: 
a. Bed Rest 
In previous studies, in which longer bed rest 
periods were used than those for the present study, no adverse 
effects were recorded. None of subjects in this study have 
developed hypercalcemia, renal stones, renal damage, decubitus 
ulcers, thrombophlebitis, syncope, fractures of the spine or long 
bones, or psychiatric problems. 
b. Radiation Hazard 
(1) 1251 - radiation dose to the bone is 
less than 5 millirem per scan at the speeds and counting rate 
used. Six determinations were performed. 
( @ 3 )  153Gd - radiation dose to the bone is 
less than 20  millirem per scan. Six such determinations were 
performed. 
( @ 4 )  Tcggm MDP - the dose of Tcggm was 100 
microcuries administered two times. This delivered approximately 
20 mr to the bladder, 6 mr to the bone, and 1 mr to the whole 
body. 
The cumulative radiation dose 
received during the 11-week experiment was within the acceptable 
limits outlined for people who work with radiation and is within 
FDA guidelines for experimental procedures in research subjects. 
c. Polyethylene Glycol 4000 
This substance is a wax-like material which is 
colorless and tasteless and has been found to have low toxicity. 
It has been studied extensively in animal and human subjects and 
has been available for many years as a solubilizer for use in 
lotions, creams, and suppositories. In addition, it is used by 
humans internally as a food additive, pill excipient, and as a 
solubilizer for toothpaste. In recent years, it has become the 
standard fecal marker for metabolic balance studies. We have 
administered this drug to 80 subjects who have participated in 
, 
our studies over the last six years without any observed side 
effects . 
d. Bone Biopsy 
Bone biopsy is usually performed as an 
outpatient procedure and the patient is allowed to leave the 
procedure room to return to his/her normal activities within 60 
to 90 minutes of the finish of the biopsy. Pain experienced 
during the procedure is usually mild. Minor analgesics are 
usually needed for one to two days and some increased sensitivity 
may persist at the biopsy site for several weeks. No serious side 
problems developed in any of the six subjects who underwent a 
bone biopsy. 
e. MR Imaging and Spectroscopy 
No side effects occurred. 
f. Muscle strength testing 
Muscle soreness occurred after the muscle 
testing because of presumed strain on the muscles in several 
subjects. 
g. Underwater Weighing 
No side effects occurred. 
h. Sodium Fluoride 
The normal intake of elemental fluoride has 
been estimated as high as 5.4 mg which is derived from both water 
and food. Water supplies range from 0.1 ppm to 3 or 4 ppm and 
occasionally higher in United States communities (@i.e., an 
intake up to 3 . 8  mg fluoride daily). 
Fluorosis, a disease of skeletal abnormalities 
associated with large intake of fluoride, has been reported and 
consists of (@a) osteosclerosis, a radiological diagnosis; (@b) 
exostosis; and (@c) calcification of ligaments with signs and 
symptoms referable to bones, ligaments and joints. Non-skeletal 
complaints and signs include chronic respiratory disease and a 
number of common non-specific disorders. The daily fluoride 
exposure necessary to bring about bony changes was estimated 
fluoride to range from 20-80 mg of elemental fluoride taken into 
the body daily for 10-20 years (49). 
Twenty five mg of elemental fluoride was given 
daily to all the fluoride treated subjects. A wax matrix tablet 
containing 12.5 mg fluoride was given twice daily. The fluoride 
preparation was sodium fluoride. The dose size and duration of 
extra elemental fluoride did not cause any ill effects to the 
research subjects. 
12. Side-effects and Adverse Reactions 
No unexpected reactions, illnesses or behavior 
occurred during the period of study. 
13. Documentation of the Study 
a. Record Keeping and Disposition of Case Reports 
and Other Documentation 
(@I) Copies of the data and other study 
documentation will be retained in the investigator's file for a 
period of at least two years. The NASA will have access if they 
so wish to the identifiers. 
14. Balance Diet 
The diet was prepared in the same fashion as in 
previous studies (6,8,10,12,13). The solid food diet was 
composed of 7 daily menus, each consisting of three meals and an 
evening snack. All foods except some staples, soft drinks, and 
meats were purchased in common lots prior to the study to assure 
maximal constancy. Fresh fruits were avoided and canned whole 
milk and frozen homogenized eggs were used. Deionized water was 
used for food preparation, drinking, and utensil cleaning. The 
subjects were required to eat all food, lick their plates, and 
drink a distilled water rinse of their glassware. On the 
average, the diet contained 1 g of calcium and 1.7 g of 
phosphorus. To determine the exact mineral and nitrogen content 
of the diet, each month duplicates of the menus for one week were 
weighed and homogenized separately, pooled, and a aliquot stored 
frozen for subsequent digestion and analysis. 
15. Serum, Stool, and Urine Collections 
Approximately 35 ml of blood was drawn every two 
weeks for complete blood count, ionized calcium, total serum 
calcium, phosphorus, creatinine, and alkaline phosphatase 
determinations. Parathyroid hormone, and calcitonin were 
assessed. An additional 30 ml of blood were drawn every 4 weeks 
for a partial thromboplastin time, erythrocyte sedimentation 
rate, lupus cell preparation, serum sodium, potassium, chloride, 
and carbon dioxide, total serum protein and albumin, serum 
bilirubin, SGOT, and BUN. Urinary protein, sugar, and sediment 
were checked weekly by the research technician. 
Urine and stools were collected between week 1 and 
10, inclusive. Twenty-four hour urines were collected daily, 
acidified with 1 ml of 12 normal HCL/100 ml urine, and stored at 
4 C. At the end of each 7-day period, total creatinine content 
of the daily urines were determined. For each subject the 7 
creatinine values were averaged and any value which was more than 
20% from the mean was discarded and a new mean obtained; any 
value which is more than 10% from the mean was assumed to 
represent a collection error and discarded. For each subject, 
the remaining urines were combined into a pool representing the 
seven-day period, and an aliquot stored at -22 C for subsequent 
analysis of calcium, phosphorus, nitrogen, and hydroxyproline. 
Seven-day collections of stools were obtained beginning and 
ending 2 4  hours after the 7-day urines to provide a partial 
correction for the intestinal transit time. Stools were 
collected in epoxy-lined 1 gallon canisters and frozen. Upon 
, 
completion of the 7-day collections, the stools were diluted with 
distilled water to a final weight approximately 3 times the 
initial weight. They were homogenized and an aliquot stored at 
-22 C for subsequent analysis of calcium, phosphorus, and 
nitrogen. Urine sample collected from volunteers receiving F 
will be analyzed for total F (not yet completed). Fecal samples 
collected from volunteers receiving F will also be analyzed for 
total F (not yet completed). 
16. Laboratory Determinations: 
Laboratory methods are referenced in Appendix A. 
Stool and diet specimens were digested in nitric 
acid for calcium determinations and in sulfuric acid for 
phosphorus and nitrogen determinations. Calcium was determined 
by atomic absorption spectrophotometry on an automated 
Perkin-Elmer Model 303. Phosphorus was analyzed by a 
modification of the Fiske and SubbaRow method, using standards 
adjusted to the pH of the samples. Creatinine was determined 
using the adaptation of the Folin Wu method. Nitrogen was 
determined after Kjeldahl digestion by the amino acid analyzer. 
Hydroxyproline was determined by the method of Kivirikko and 
Prockop, and alkaline phosphatase was determined by the automated 
modification of the Bessey-Lowry-Brock method. All methods have 
been validated by recovery studies which were repeated 
periodically, and quality control was maintained by including 
standards in all runs. All assays were carried out in duplicate 
and results accepted only when the disparity between the two 
determinations was less than 5%. 
11. RESULTS 
add results here! 
111. DISCUSSION 
The human skeleton goes through two major phases during 
life: (@1) growth (@modeling) and (@2) repair of micro-defects 
(@remodeling) . Major growth stops when the skeletal epiphyses 
close and the human reaches their maximal height. Modeling 
continues along the periosteal and cortical-endosteal bone 
surfaces: however, it is thought to be insignificant and rarely 
is involved in the pathophysiology of metabolic bone disease 
acquired during adult life. 
Remodeling in the human begins at birth and continues 
throughout life. The metabolic bone diseases in the adult are 
because of remodeling activity. Remodeling occurs in all areas of 
the skeleton, i.e., periosteal, haversian, cortical-endosteal and 
trabecular. Bone remodeling directly determines the speed of bone 
tissue turnover, the quantity of unmineralized osteoid, the total 
and relative amounts of resorption or formation surfaces and the 
net gain or loss of bony tissue on a particular skeletal surface. 
, 
Frost has defined the actions of bone remodeling by 
describing the happenings thus; a Ilpacket" of bone (@Basic 
Multicellular Unit, BMU) is activated by some messenger (25). 
This causes proliferation and then differentiation of mesenchymal 
cells in the affected region of bone. The cells, which now can be 
identified as osteoclasts, begin bone resorption by solubilizing 
both the organic and inorganic components of pre-existing bone. 
(@Osteoclastic activity stops and the osteoclasts disappear.) 
Osteoblasts, derived from the marrow, appear on the resorbed 
surface and proceed to make new organic bone matrix and in some 
manner initiate the matrix's mineralization. The quantity of new 
bone is equal to the old bone being replaced. The duration of 
remodeling events is thought to take about 3 to 4 months with 
resorption phase lasting about 1 month and the formation phase 
lasting 2 to 3 months (37). 
The following parameters can be measured using 
histomorphometry: presence of woven bone, extent of resorption, 
depth of resorption, extent of formation, extent of osteoid, 
thickness of osteoid, extent of mineralization front, mineral 
appositional rate and surface cell morphology. 
Disuse osteoporosis is postulated to occur during space 
flight. Net bone loss occurs because bone resorption is grater 
than bone formation. This theory for osteoporosis has been 
confirmed in Earth-bound paraplegics, an extreme disuse state, by 
bone biopsy ( 2 4 ) .  Although the activation factor initiating 
disuse osteoporosis is not known, specific changes in bone 
histomorphometry would be expected to occur in untreated bed 
rest. 
F 
histological 
osteoblastic 
therapy may cause profound changes in the 
pattern of a bone biopsy. F is known to stimulate 
activity (34,35) which can increase the number of 
osteoid sites as well as osteoid thickness (38). Additionally 
during F therapy appositional woven bone may be formed instead of 
the normal development of lamellar bone (37). 
Since relatively low dose F will be given to the 
research subjects participating in this experiment, it will be 
very important to evaluate the bone directly as well as with 
metabolic balance and bone densitometry techniques. 
Measurement of Bone Loss 
In addition to the usual measurement of bone mineral by 1251 
photon absorptiometry rectilinear scanning of the calcaneus (19), 
measurement of the lower lumbar vertebrae was done using the dual 
photon 153Gd ( 2 2 ) .  This allowed a direct comparison among these 
two techniques and the metabolic calcium balance method. Bone 
turnover was measured by calcium kinetic studies using Tc99m MDP. 
Bone histomorphometric changes during bed rest induced 
osteoporosis have not been reported. We have obtained bone 
biopsies in 6 bed rested subjects, 3 controls and 3 treated with 
20 mg F, at 5 weeks of bed rest. Preliminary data is not yet 
available. Bone biopsies have been performed in paraplegics who 
were untreated or who received clodronate (24). 
Measurement of Muscle Volume and Strength 
The long term bed rest protocol allows investigation into 
the nature and extent of muscular atrophy. Magnetic Resonance 
Imaging (@MRI), a new technique, to measure both muscle volume 
and metabolic consequences of inactivity can be compared to the 
standard methodology for determining muscle peak strength and 
maximal duration of muscular activity during exercise. A separate 
proposal has been submitted to NASA for the MRI technique to be 
used in this study. 
Hormonal Mechanisms in Disuse Osteoporosis 
Hormonal responses to (@1) activity and nutrient intake 
during ambulation and recumbency were monitored longitudinally to 
measure the variation of parathyroid hormone (@PTH), calcitonin 
(@CT), calcitriol, and cortisol. 
Nephrolithiasis 
Nephrolithiasis is a definite potential complication of 
space flight (31). The limited data available suggest that the 
metabolic changes during space flight could lead to renal stone 
formation. 
Hypercalciuria develops soon after space flight and calcium 
excretion may approach 500 mg/day (32). The excessive renal loss 
of calcium is probably skeletal in origin, since it is correlated 
with the development of negative calcium balance (5,32,33) and 
loss of bone mass (9) and occurs despite probable reduced 
intestinal calcium absorption. Urinary phosphate excretion is 
also increased during space flight probably by the same mechanism 
(5,32,33). These changes would place the astronaut at an 
increased risk for stone formation by increasing urinary 
saturation of stone-forming calcium salts (@calcium oxalate and 
calcium phosphate) (39). 
Two other factors may contribute to stone formation during 
space flight. Potassium deficiency, resulting from an exaggerated 
renal loss of potassium ( 4 8 ) ,  may reduce renal excretion of 
citrate (40), a well recognized inhibitor of the crystallization 
of calcium salts (39). Moreover, urinary uric acid may be high 
because of increased availability of purine substrate (@due to 
muscle degradation or use of a high protein diet). The resulting 
hyperuricosuria may predispose to uric acid lithiasis or to 
calcium nephrolithiasis via monosodium urate-induced 
crystallization of calcium salts (41). The exaggerated renal loss 
of sodium ( 4 8 )  may further promote the latter mechanism. 
The risk factors which may primarily predispose astronauts 
to renal lithiasis in addition to those discussed above include 
dehydration and high animal protein intake. It has been 
impossible to determine the water balance of astronauts during 
the initial stages of flight for a number of reasons. However, it 
can be postulated that sweating, early limited access to water, 
and space motion sickness causes decreased appetite-thirst and 
therefore increased urine concentration. As previously mentioned, 
an apparent dietary preference for a high meat diet may 
accentuate a tendency toward stone formation. There is 
substantive epidemiological and biochemical data suggesting that 
an excessive consumption of animal protein confers an important 
risk for stone formation ( 4 2 ) .  A high animal protein diet has 
been shown to increase urinary calcium and uric acid ( 4 2 )  and 
lower urinary citrate ( 4 3 ) .  
From the data generated in this study, it may be possible to 
formulate an effective preventive program for nephrolithiasis. 
Reliable techniques are now available to quantitate various steps 
in the stone-forming salts (@uric acid, monosodium urate, calcium 
phosphate and calcium oxalate) may be reliably measured from the 
activity product ratio or relative saturation ratio ( 4 4 , 4 5 ) .  The 
inhibitor activity against spontaneous nucleation of calcium 
phosphate and calcium oxalate may be determine in whole urine 
from the formation product ratio ( 4 5 ) .  The propensity for 
spontaneous nucleation may be estimated from the formation 
product ratio minus the activity product ratio discriminant 
scores (39) or permissible increments ( 4 6 ) .  
The above physicochemical measures were utilized to 
quantitate the response in any proposed treatment program to 
reduce urinary saturation and/or increase inhibitor activity. A 
separate NASA research grant was submitted for this part of the 
experiment and will be reported in another communication. 
IV. SIGNIFICANCE OF THE RESEARCH 
Sodium fluoride has received attention because of its 
potential therapeutic usefulness in a wide variety of skeletal 
disorders. It has been shown to retard the dissolution of 
hydroxyapatite crystals in vitro. 
Previous space missions have used only distilled water and 
a low fluoride diet. The average intake of fluoride from the 
usual community water supply is 2 . 3 5  mg/day (@l ppm) compared to 
all other dietary intake of 2 mg/day. Studies in the PI'S 
laboratory have shown fluoride balances, reflecting fluoride 
intake from distilled water and a whole food diet, to be slightly 
negative. This may have played a role in the developement of 
disuse osteoporosis which occurred during the Skylab mission and 
in the early bed rest studies. 
In addition, during the last few years, the use of fluoride 
has been tried as therapy to increase bone mass and reverse 
osteoporotic disease. It has been stated that the fluoride ion 
is the only pharmaceutical that appears to be capable of the dual 
effects of increasing bone mass at the same time it stops disease 
progression. This mode of therapy is extensively used in many 
areas, and this study has produced additional information 
regarding fluoride balance in normal people and its role in the 
prevention of disuse osteoporosis. 
A number of physiological changes have been demonstrated 
in bone, muscle, and blood after exposure of humans and animals 
to microgravity. Determining mechanisms and the development of 
effective countermeasures for long-duration space missions is an 
important NASA goal. Historically, NASA has had to rely on tape 
measures, x-ray, and metabolic balance studies with collection of 
excreta and blood specimens to obtain this information. The 
advent of tomographic magnetic resonance imaging (@MRI) offers 
the possibility of greatly extending these early studies in ways 
not previously possible; MRI is also noninvasive and safe, i.e., 
no radiation exposure. MRI provides both superb anatomical 
images for volume measurements of individual structure and 
qualification of chemical/physical changes induced in the 
examined tissues. Results of this aspect of the study will be 
reported later. 
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